BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
PRKCA
,
Metabolism of xenobiotics
,
Diabetes mellitus
,
Pancreas
,
Alcohol
,
Tamoxifen
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
EphA2 receptor
Summary
General Info
Curated Studies
Most Correlated Studies
Non-small cell lung cancer NCI-H1299 cells with siRNA knockdown of EPHA2 and treated with HGF
Breast cancer MCF7 cells expressing different HER2 N-term deletions
Pancreatic ductal adenocarcinomas and liver and peritoneal metastases
Explore Curated Studies Results
Literature
Most Relevant Literature
A computational and laboratory approach for the investigation of interactions of peptide conjugated …
Phase I trial of convection-enhanced delivery of IL13RA2 and EPHA2 receptor targeted cytotoxins in d…
Probing the effect of clustering on EphA2 receptor signaling efficiency by subcellular control of li…
Lithocholic acid-tryptophan conjugate (UniPR126) based mixed micelle as a nano carrier for specific …
Conformational Clamping by a Membrane Ligand Activates the EphA2 Receptor.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
CAR-T Cell Immunotherapy for EphA2 Positive Malignant Glioma Patients
EphA2 siRNA in Treating Patients With Advanced or Recurrent Solid Tumors
Safety and Bioimaging Trial of DS-8895a in Patients With Advanced EphA2 Positive Cancers
Personalized Chimeric Antigen Receptor T Cell Immunotherapy for Patients With Recurrent Malignant Gl…
A Toll-like Receptor Agonist as an Adjuvant to Tumor Associated Antigens (TAA) Mixed With Montanide …
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ